TG Therapeutics
TGTX
#3080
Rank
$4.89 B
Marketcap
$30.83
Share price
0.23%
Change (1 day)
-6.12%
Change (1 year)

Revenue for TG Therapeutics (TGTX)

Revenue in 2025 (TTM): $0.53 Billion USD

According to TG Therapeutics's latest financial reports the company's current revenue (TTM ) is $0.53 Billion USD. In 2024 the company made a revenue of $0.32 Billion USD an increase over the revenue in the year 2023 that were of $0.23 Billion USD. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for TG Therapeutics from 1996 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) $0.53 B61.67%
2024 $0.32 B40.8%
2023 $0.23 B8293.07%
2022 $2.78 M-58.38%
2021 $6.68 M4300.66%
2020 $0.15 M0%
2019 $0.15 M0%
2018 $0.15 M-0.06%
2017 $0.15 M-0.19%
2016 $0.15 M0%
2015 $0.15 M0%
2014 $0.15 M0%
2013 $0.15 M699.98%
2012 $0.01 M
2011 N/A
2010 N/A
2009 N/A
2000 $5.35 M346.58%
1999 $1.2 M-62.5%
1998 $3.2 M966.67%
1997 $0.3 M0%
1996 $0.3 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Dr. Reddy's Laboratories
RDY
$3.95 B 644.06%๐Ÿ‡ฎ๐Ÿ‡ณ India
Alkermes
ALKS
$1.52 B 186.02%๐Ÿ‡ฎ๐Ÿ‡ช Ireland